These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9424585)

  • 21. Heparin in acute coronary disease--requiem for a heavyweight?
    Armstrong PW
    N Engl J Med; 1997 Aug; 337(7):492-4. PubMed ID: 9250854
    [No Abstract]   [Full Text] [Related]  

  • 22. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
    Nguyen-Ho P; Levine GN
    Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches to the treatment of unstable angina and non-Q wave myocardial infarction.
    Cohen M
    Can J Cardiol; 1998 Aug; 14 Suppl E():11E-14E. PubMed ID: 9779027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reliable anticoagulation in acute myocardial infarction. Acute coronary syndromes: advances with low-molecular heparin therapy].
    Z Kardiol; 1998 Dec; 87(12 Suppl Akute Koro):1-4. PubMed ID: 9884738
    [No Abstract]   [Full Text] [Related]  

  • 27. Low-molecular-weight heparins for unstable angina. A better mousetrap?
    Waters D; Azar RR
    Circulation; 1997 Jul; 96(1):3-5. PubMed ID: 9236404
    [No Abstract]   [Full Text] [Related]  

  • 28. [Heparin in the treatment of unstable angina. Can the decrease of the molecular size increase its effectiveness?].
    Panchenko EP
    Ter Arkh; 1998; 70(12):71-4. PubMed ID: 10067259
    [No Abstract]   [Full Text] [Related]  

  • 29. [Low-molecular-weight heparin in unstable angina pectoris].
    Ocampo S; Solorio S; Rangel A; León FJ; Lepe L; Ayala F; Madrid R; Romero MA; Carrillo AM
    Arch Inst Cardiol Mex; 1999; 69(3):222-7. PubMed ID: 10529855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of controlled clinical trials comparing low-molecular weight heparins with unfractionated heparin in unstable angina.
    Malhotra S; Karan RS; Bhargava VK; Pandhi P; Grover A; Sharma YP; Kumar R
    Indian Heart J; 2001; 53(2):197-202. PubMed ID: 11428477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.
    Cohen M
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin should be administered to every patient admitted to the hospital with possible unstable angina.
    Brewster GS; Herbert ME
    West J Med; 2000 Aug; 173(2):138-40. PubMed ID: 10924445
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.
    Turpie AG
    Can J Cardiol; 1998 Aug; 14 Suppl E():20E-23E. PubMed ID: 9779029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of unstable angina and myocardial infarction.
    Cohen M; Turpie AG
    Lancet; 2000 Sep; 356(9236):1193-4. PubMed ID: 11030322
    [No Abstract]   [Full Text] [Related]  

  • 36. Unstable angina and non-Q-wave myocardial infarction. Treatment beyond aspirin and heparin.
    Theroux P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):799. PubMed ID: 12497824
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of un-fractionated heparin and low molecular weight heparin on hospital mortality in patients with non ST elevation acute coronary syndrome (ACS).
    Angkasuwapala K; Ratanasumawong K; Ngarmukos T; Kehasukcharoen W; Boonsom W; Kamsa-ard S
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():109-14. PubMed ID: 18431893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of low molecular weight heparin on unstable angina].
    Jiang DQ; Wen D; Zhou SH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):340-2. PubMed ID: 12536729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice].
    Ottani F; Ferrini D; Di Pasquale G; Galvani M
    Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin.
    Antman EM; Kereiakes DJ
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E1-4;discussion E25-8. PubMed ID: 11156721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.